Health Care • Medical Electronics
$7.51 ▼ -0.30
(-3.84%)
MKT CAP: $2.00B • VOL: 5.90M
52W L $2 52W H $10
BFLY // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $97.6M | $82.1M | $65.9M |
| YoY Revenue Growth % | +19.0% | +24.5% | — |
| Gross Profit | $45.7M | $48.8M | — |
| Gross Margin % | 46.9% | 59.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$86.4M | -$74.4M | -$145.6M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$77.1M | -$72.5M | -$133.7M |
| EBITDA (Normalized) | -$83.7M | -$72.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$12.7M | -$41.7M | -$98.8M |
| Capital Expenditures (CapEx) | $3.3M | $2.7M | — |
| Free Cash Flow (FCF) | -$16.0M | -$44.4M | -$98.8M |
| FCF Margin % | -16.4% | -54.1% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $150.5M | $88.8M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $196.0M | $168.8M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR BFLY.